“I confirm, I have read the Viatris Privacy Notice and agree that Viatris Inc., its affiliates and subsidiaries (“Viatris”) may use my personal data to provide me with scientific information and information on pharmaceutical products as well as events, webinars or surveys. I understand and acknowledge that all information processed by Viatris is handled in accordance with local privacy laws and may be captured and processed in countries outside of the jurisdiction in which it was collected. In order to improve its emails, websites and information services, Viatris may track whether I received an email, opened it, clicked on any links, viewed or downloaded any documents within it. I understand that my consent is voluntary and I can withdraw my consent at any time. The withdrawal of consent will not affect the lawfulness of processing based on consent before its withdrawal. I acknowledge that I am not obliged to provide my personal information. However, if I do not provide the information, I may not, for example, be able to participate fully in activities managed by Viatris”.

Viatris makes no claim or warranty of, and is not responsible for, any medical, scientific or other information that may be disseminated through this programme. Viatris does not make, and expressly disclaims, any representations or warranties of any kind, either express or implied (including, without limitation, any implied warranties of content or non-infringement) with regard to any such information, its accuracy or completeness. This scientific meeting is for the purpose of education and discussion only. Statements of fact and opinions expressed are those of the Speaker(s) and are not the opinion or position of Viatris. Viatris does not recommend the use of its products in any manner inconsistent with that described in the full prescribing information. Nothing contained in this programme/ presentation should be construed as medical advice or should replace treatment or recommendations from qualified health care providers which may vary patient to patient.

I hereby release, waive and forever discharge any and all liability, claims, and demands of whatever kind or nature against Viatris Inc. and all associated companies (defined as: any other company, partnership or other entity controlled by, controlling or in common control with the Viatris inc. including any subsidiaries and affiliates of Viatris inc. and within Viatris Inc.’s group) including, without limitation, its directors, officers, employees, volunteers, and agents (the “released parties”), either in law or in equity, to the fullest extent permissible by law, including but not limited to damages or losses caused by the negligence, fault or conduct of any kind on the part of the released parties, including but not limited to death, bodily injury, illness, economic loss or out of pocket expenses, or loss or damage to property, which I, my heirs, assignees, next of kin and/or legally appointed or designated representatives, may have or which may hereinafter accrue on my behalf, which arise or may hereafter arise from my participation in the activity.

I agree that Viatris sends me both promotional and non-promotional healthcare related email communication via an appointed Viatris sales representative. In order to improve its emails, websites and information services, Viatris may track whether I received an email, opened it, clicked on any links, viewed or downloaded any documents in it.

My consent is voluntary. I can withdraw my consent at any time. The withdrawal of consent will not affect the lawfulness of processing based on consent before its withdrawal.

Viatris is a new global healthcare company formed from the combination of Mylan and UpJohn, a legacy division of Pfizer.